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Abstract
Background: Sentinel node (SN) biopsy has been practiced in gastric cancer in recent years, and many studies
focused on the distribution of solitary lymph node metastasis (SLM) to assess the pattern of SN. In fact, there is
usually more than one SN existing in gastric cancer. The distribution of SNs needs to be further re-evaluated.
Methods: A total of 289 patients in pT1-2 stage with 1-3 positive nodes confined to same compartment were
included in this study with informed consents. The primary lesion was solitary (≤ 5.0 cm in diameter) and D2 or D3
lymph node dissection had been performed. The location of metastatic lymph nodes was analyzed retrospectively.
Results: Most positive nodes occurred in N1 compartment, with frequency of 79.6% to 85.7% based on site of
tumor. In the lower third of stomach, no. 6 was the most common metastatic site and no. 3 was the second; the
order was reversed for SLM. With increasing depth of tumor invasion, a progressively augmented nodal
involvement was shown. Nearly a half appeared transverse metastasis when the tumor located at the lesser or
greater curvature. Among skip metastasis, no. 7, 8a, 9 and 11p were the most common metastatic sites and the
prognosis was as similar as that of patients with N1 involved only.
Conclusions: The 1-3 positive nodes in the same compartment should be possible SNs, and most of which are
restricted in N1 in pT1-2 gastric cancer. Transversal and 2 stations lymph node metastasis are common.
Background
Although the incidence of gastric cancer is declining, it
remains the second leading cause of cancer related mor-
tality worldwide [1-3]. Lymph node status is one of the
crucial important prognostic factors, and gastrectomy
with D2 or D3 lymphadenectomy is still considered as
t h eo n l yt r e a t m e n to f f e r i n gh o p eo fac u r ef o rg a s t r i c
cancer. However, the incidence of nodal involvement in
gastric cancer is significantly different according to the
depth of tumor invasion (T1-T4) [4-7]. Uniform applica-
tion of this highly invasive procedure would increase
morbidity and reduce the quality of life after surgery,
especially for those with early stage cancers. However,
the optimal strategy of lymphadenectomy for gastric
cancer is still under debate.
Sentinel node (SN) is defined as the first lymph node
which receives lymphatic drainage from the primary
tumor. Sentinel node biopsy (SNB) has been widely
applicated as an alternate treatment to maintain the
quality of life for cT1-2 gastric cancer patients in recent
years. However, this technique is still unsatisfactory for
clinical application due to its high heterogeneity in sen-
sitivity, specificity and accuracy (from 61.1% to 100%)
[8-12]. There are several potential explanations for these
results: 1) different examining methods which need to
be standardized; 2) limited sample size of participants
and sentinel nodes examined; 3) patients in late stage
included occasionally; 4) multidirectional and compli-
cated lymphatic flow from stomach. Resolving the above
problems could improve the accuracy of SNB practice
in gastric cancer.
Up to now, many studies have investigated the locali-
zation and distribution of solitary lymph node metasta-
sis (SLM) in order to provide some useful information
for SN concept in gastric cancer, which may offset the
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[13-16]. However, the lymphatic drainage of the
stomach is considerably more complex than that of
ectodermal organs like breast and skin. The multidir-
ectional and complicated lymphatic flow from stomach
results in more than one node, which should be con-
sidered as SN for gastric cancer. Furthermore, many
investigations have showed that the number of SN per
p a t i e n ti s1 - 1 2w i t ha na v e r a g eo f3[ 8 , 1 7 - 1 9 ] .C o n s e -
quently, using SLM to assess the distribution of SNs in
gastric cancer may leave out some important informa-
tion, thus it might be more appropriate to practice the
SN concept based on more than one metastatic lymph
node.
In the light of these considerations, the aim of the
present study was to assess the distribution of 1-3 posi-
tive nodes in pT1-2 gastric cancer patients. This would
provide some new information for the concept of SNs
in gastric cancer, especially in early stage of tumor.
Methods
A retrospective analysis of clinicopathologic data for
gastric cancer patients from a prospectively collected
gastric cancer database from February 1980 to November
2006, at the Department of Surgical Oncology, First
Affiliated Hospital, China Medical University, was per-
formed. The criteria for inclusion in this study were as
follows: (1) primary lesion was solitary (≤ 5.0 cm in dia-
meter) and limited to one part of the stomach; (2)
patients were in pT1-2 stage according to the 6
th UICC/
TNM classification; (3) D2 or D3 lymph node dissection
had been performed; (4) patients had 1-3 metastatic
lymph nodes which restricted to the same compartment
according to JCGC; (5) the number of examined lymph
node was more than 10; (6) all the patients clinically
staged as no macroscopic serosal invasion (cT1-2) and
node negative (cN0) before or during surgery. A total of
297 patients with gastric cancer were included. At the
end of follow-up in December 2008, 4 patients died in
the postoperative period and 4 patients were lost, with
the follow-up rate of 97.3%. The median and mean fol-
low-up period was 45.0 and 68.8 months (3-342 months),
respectively. Overall, 289 patients with gastric cancer
were enrolled into this study with their informed
consents.
We first retrospectively investigated the localization
and distribution of 1-3 positive nodes confined to the
same compartment according to Japanese Classification
of Gastric Carcinoma (JCGC), which were regarded as
possible sentinel lymph nodes, and then compared those
with solitary lymph node metastasis (SLM). The differ-
ences were identified between the two groups. Then the
clinical and pathological features were analyzed for
patients with transversal and two stations metastasis.
The study protocol was approved by the Ethics Com-
mittee of China Medical University.
Statistical analysis
Data were analyzed using the SPSS statistical software
(SPSS, Chicago, IL). The difference of nodes distribution
between SLM and 1-3 positive nodes was tested by the
chi-square test or Fisher’s exact probability test. The
univariate analysis was used by the chi-square test for
categorical variables and unpaired t-test for continuous
variables between groups. The multivariate analysis was
used binary logistic regression. The survival analysis was
used by Kaplan-Meier estimation and log-rank test. P <
0.05 was considered to be statistically significant.
Results
Clinicopathologic features
Among the patients, the age (mean ± SD) was 58.9 ±
1 0 . 4y e a r s( r a n g i n gf r o m2 9t o8 4y e a r s ) .M o r em e n
than women (224 men versus 65 women) participated in
the study. Carcinomas were located in the lower third of
stomach (L) in 207 patients, middle third (M) in
28 patients and upper third (U) in 54 patients. Tumors
were located in the lesser curvature in 131 patients and
in the greater curvature in 63 patients, respectively. Dis-
tal-gastrectomy was executed in 223 patients, proximal-
gastrectomy in 47 patients and total-gastrectomy in
19 patients. Lymphadenectomy was executed based on
the Japanese Classification of Gastric Carcinoma (JCGC)
[20]. D2 lymph node dissection was performed in 212
patients, and D3 in 77 patients. The number of lymph
node retrieved ranged from 10 to 55 with an average of
20.9 ± 9.9 (mean ± SD). Among them 10-14 retrieved
nodes were in 97 patients and ≥ 15 retrieved nodes in
192 patients, respectively.
According to the depth of tumor invasion, pT1 cancer
was diagnosed in 28 patients (9.7%), with protruded
type (I, IIa) in 3 patients (10.7%) and depressed type
(IIc, III) in 25 patients (89.3%), respectively. The pT2a
cancer was diagnosed in 92 patients (31.8%), and pT2b
cancer in 169 patients (58.5%), with Borrmann I/II in
54 patients (20.7%) and Borrmann III/IV in 207 patients
(79.3%) based on macroscopic type. The tumor diameter
ranged from 0.5 to 5.0 cm with an average of 3.9 ± 1.1
cm (mean ± SD). Well and/or moderately differentiated
tumor was found in 129 patients (44.6%), and poorly
differentiated tumor in 160 patients (55.4%) according
to the histology. Diffuse-type was found in 170 patients
(58.8%), intestinal-type in 111 patients (38.4%), and
mixed-type carcinoma in 8 patients (2.8%) based on
Lauren classification. SLM was found in 173 patients,
2 positive nodes in 75 patients, and 3 positive nodes in
41 patients, respectively. The metastatic lymph node
restricted to one station was in 235 patients and two
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N1 compartment nodes were involved in 237 patients
and N2 (skip metastasis) in 52 patients in light of JCGC.
Location and distribution of 1-3 metastatic lymph nodes
in gastric cancer
Among 207 patients with lower-third tumor, 170 patients
(82.1%) had lymph node metastasis in the perigastric
nodes (N1) close to the primary tumor and no. 6/3 was
the most common site. The other 37 patients (17.9%)
were found in N2 without N1 involvement. Of 28
patients with middle-third tumor, 24 patients (85.7%)
had lymph node metastasis in N1 and skip metastasis
was found in 4 patients (14.3%). In 54 patients with
upper-third tumor, 43 patients (79.6%) metastasized in
N1, and skip metastasis occurred in 11 patients (20.4%).
In N2 compartment, no. 11p and 12a were also involved
apart from no. 7, 8a and 9. The detailed frequency of
different station involved in N1 and N2 was displayed in
table 1.
Difference of location and distribution between SLM and
1-3 positive nodes in gastric cancer
With respect to the tumor in lower third of stomach,
there was no significant difference in frequency and dis-
tribution of skip metastasis between SLM and 1-3 posi-
tive nodes, and the no. 7, 8a and 9 were the most
common target stations. In N1 compartment, the fre-
quency of no. 5 and no. 6 involved in patients with 1-3
positive nodes was higher than that in patients with
SLM (p < 0.05). Furthermore, in patients with 1-3 positive
nodes no. 6 was the most common metastatic site, and no.
3 was the second, this was reversed to that in patients with
SLM. As to the tumor in middle and upper third of
stomach, the location and distribution of metastatic node
in N1 and N2 compartment was similar in patients
with SLM and 1-3 positive nodes, there was no significant
difference (p > 0.05) (Table 2).
Pattern of distribution of 1-3 metastatic lymph nodes in
gastric cancer according to the depth of tumor invasion
Among the tumors of different depth of invasion (T1,
T2a and T2b), the pattern of lymph node metastasis in
N1 and N2 compartment was similar. With an increase
of T parameter, a progressively augmented nodal invol-
vement was showed in some stations. In lower third of
stomach, no. 6 was the most common station, from 25%
in T1 to 39% in T2a, and to 36.4% in T2b tumors. The
no. 3 was the second common, from 25% in T1 to 26%
in T2a, and to 33.6% in T2b tumors. The no. 1 and no.
9 was not involved in T1 tumors, but was involved in
T2a and T2b tumors. In middle third of stomach, no. 3
was the most common station, 40% in T1, 37.5% in T2a
and 53.3% in T2b tumors. In upper third of stomach,
no. 1 and no. 3 was the common metastatic site, and
the frequency of N2 involved was much higher in T2b
than that in T2a and T1 tumors. The skip metastasis
often occurred in no. 7, 8a, 9, 10, and 11p in T2b
tumors, but it seldom occurred in T2a and T1 tumors
(Table 3).
Transversal and two stations metastasis with 1-3
metastatic lymph nodes in gastric cancer
A total of 32 (50.8%) in the 63 patients with tumor in
the greater curvature side had transversal metastasis.
There were 5 cases metastasis in no. 1 station and 4
cases in no. 3 station among 13 patients in the upper
third of stomach, and 2 cases in no. 3 and 1 case in
no. 5 among 5 patients in the middle, and 14 cases in
no. 3 and 6 cases in no. 5 among 45 patients in the
lower third of stomach. 54 (41.2%) in the 131 patients
with tumor in the lesser curvature side had transversal
metastasis. There were 5 cases in no. 2 among 22 patients
in the upper third of stomach, and just 1 case in no. 6
among 11 patients in the middle, and 15 cases in no. 4
and 33 cases in no. 6 among 98 patients in the lower
third of stomach.
With respect to patients with two stations involved, in
34 tumors located in the lower third of stomach, 11
(32.4%) patients metastasized simultaneously in no. 5/6.
No. 3/4 and no. 3/6 were both involved in 6 (17.6%)
and 7 (20.6%) patients, respectively. The rest patients
m e t a s t a s i z e di nn o .4 / 5 ,n o .4 / 6a n dn o .3 / 5 .O fn o t e ,
2 cases metastasized in no. 7/8a without N1 involvement.
Table 1 Localization and distribution of 1-3 positive
lymph nodes in 289 patients with gastric cancer
Tumor Location
station L (%) M (%) U (%)
no.1 8 (3.9) 3 (10.7) 24 (44.4)
no.2 - 1 (3.6) 9 (16.7)
no.3 62 (30.0) 13 (46.4) 15 (27.8)
no.4d 37 (17.9) 6 (21.4) 4 (7.4)
no.5 29 (14.0) 5 (17.9) 0
no.6 75 (36.2) 2 (7.1) 0
no.7 12 (5.8) 3 (10.7) 6 (11.1)
no.8a 13 (6.3) 1 (3.6) 4 (7.4)
no.9 3 (1.4) 0 2 (3.7)
no.10 0 - 1 (1.9)
no.11p 3 (1.4) 0 2 (3.7)
no.12a 0 1 (3.6) 0
compartment (JCGC)
N1 170 (82.1) 24 (85.7) 43 (79.6)
N2 37 (17.9) 4 (14.3) 11 (20.4)
number of station
1 172 (83.1) 21 (75.0) 41 (75.9)
2 35 (16.9) 7 (25.0) 13 (24.1)
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Lower third (%) Middle third (%) Upper third (%)
station SLM 1-3 x p SLM 1-3 x p SLM 1-3 x p
no.1 6.2 3.9 0.96 0.328 5.9 10.7 0.31 0.581 33.3 44.4 0.92 0.337
no.2 - - - - 5.9 3.6 0.13 0.715 18.5 16.7 0.04 0.835
no.3 27.9 30 0.16 0.688 41.2 46.4 0.12 0.731 29.6 27.8 0.03 0.862
no.4d 15.5 17.9 0.32 0.573 17.6 21.4 0.10 0.758 7.4 7.4 0.00 1.000
no.5 6.9 14 3.92 0.048* 11.8 17.9 0.30 0.585 0 0.0 - -
no.6 25.6 36.2 4.13 0.042* 0 7.1 1.27 0.260 0 0.0 - -
no.7 7.8 5.8 0.50 0.481 11.8 10.7 0.01 0.913 7.4 11.1 0.28 0.598
no.8a 6.9 6.3 0.06 0.802 5.9 3.6 0.13 0.715 3.7 7.4 0.43 0.514
no.9 2.3 1.4 0.35 0.555 0 0.0 - - 0 3.7 1.03 0.311
compartment
N1 76.0 82.1 1.87 0.172 82.4 85.7 0.09 0.763 88.9 79.6 1.91 0.167
N2 24.0 17.9 17.6 14.3 11.1 20.4
note: SLM refers to solitary lymph node metastasis; 1-3 refers to 1-3 positive nodes.
* indicates the difference is significant.
Table 3 Incidence of 1-3 positive lymph nodes in gastric cancer patients according to the depth of tumor invasion (%)
Lower third Middle third Upper third
station T1 T2a T2b T1 T2a T2b T1 T2a T2b
no.1 0 2
(2.6)
6
(5.5)
3
(60.0)
00 1
(33.3)
5
(71.4)
18
(40.9)
no.2 - - - - 1
(12.5)
00 1
(14.3)
8
(18.2)
no.3 5
(25.0)
20
(26.0)
37
(33.6)
2
(40.0)
3
(37.5)
8
(53.3)
1
(33.3)
2
(28.6)
12
(27.3)
no.4d 6
(30.0)
15
(19.5)
16
(14.5)
01
(12.5)
5
(33.3)
00 4
(9.1)
no.5 2
(10.0)
12
(15.6)
15
(13.6)
02
(25.0)
3
(20.0)
00 0
no.6 5
(25.0)
30
(39.0)
40
(36.4)
01
(12.5)
1
(6.7)
00 0
no.7 2
(10.0)
5
(6.5)
5
(4.5)
02
(25.0)
1
(6.7)
1
(33.3)
06
(13.6)
no.8a 1
(5.0)
3
(3.9)
9
(8.2)
1
(20.0)
00 - 0 3
(6.8)
no.9 0 2
(2.6)
1
(0.9)
000 - - 2
(4.5)
no.10 - - 0 - - - - - 1
(2.3)
no.11p - 1
(1.3)
2
(1.8)
-00 - 02
(4.5)
no.12a 00001
(12.5)
0- 00
compartment (JCGC)
N1 18
(90.0)
64
(83.1)
88
(80.0)
4
(80.0)
6
(75.0)
14
(93.3)
2
(66.7)
7
(100.0)
34
(77.3)
N2 2
(10.0)
13
(16.9)
22
(20.0)
1
(20.0)
2
(25.0)
1
(6.7)
1
(33.3)
-1 0
(22.7)
number of station
11 9
(95.0)
65
(84.4)
89
(80.9)
4
(80.0)
5
(62.5)
12
(80.0)
3
(100.0)
6
(85.7)
32
(72.7)
21
(5.0)
12
(15.6)
21
(19.1)
1
(20.0)
3
(37.5)
3
(20.0)
-1
(14.3)
12
(27.3)
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pathologically. Among 7 patients in the middle, no. 3/4,
no. 5/6 and no. 1/3 were common metastatic stations. In
13 patients located in the upper third of stomach, no. 1/3
were the most common target sites, metastasized in 4
(30.8%) patients. It was worth noting that 4 cases with
two stations involved appeared in N2 compartment (no.
8/9, no. 9/11, no. 8/10 and no. 7/11 stations involved,
respectively), which amounted to 1.1% in 44 patients of
upper third of stomach with 1-3 positive nodes, and who
were all proved as ss (pT2b) pathologically.
In order to find some associated factors with transver-
sal and 2 stations node involved, the correlation between
clinicopathological features and them was analyzed.
However, there was no significant association between
them (detailed in table 4). The most possible reason for
the high frequency of transversal and 2 stations lymph
node metastasis might be the multidirectional and com-
plicated lymphatic flow from stomach.
Influenced factors and survival analysis of skip metastasis
A total of 52 patients occurred skip metastasis. In order
to find factors influencing skip metastasis, the correla-
tion was assessed between skip metastasis and clinico-
pathologic factors which includes gender, age, tumor
location, tumor size, macroscopic type, differentiation,
Lauren classification, depth of tumor invasion and vessel
involvement. As a result, no clinicopathologic factor was
found to be associated with skip metastasis using uni-
variate and multivariate analysis (data not shown).
A little decrease of survival rate was showed in
patients with skip metastasis. The 5-year, 10-year survi-
val rate in patients with and without skip metastasis was
55.3%, 49.7% and 68.2%, 61.3%, respectively. However,
no significant difference was detected between the
two groups (x
2 = 0.168, p = 0.1951) using log rank test
(figure 1), which meant the prognosis of patients with
skip metastasis (N2) was as similar as that of patients
with N1 involvement.
Discussion
In order to accurately assess the sentinel lymph node
distribution in gastric cancer, the criteria for inclusion
in this study were defined very strictly. First, the primary
tumor of 5.0 cm or less in diameter ensured that the
lesion occupied only one part of the stomach, which
could diminish the interactive effect from location over-
lap. Ichikura T et al. assessed the applicability of the
sentinel node concept to gastric carcinoma based on
119 patients with a primary tumor ≤ 5.0 cm in diameter
[21]. Yasuda K et al. defined a tumor measuring ≥ 5.0
cm as superficially spreading cancer of the stomach
[22]. These literatures also support that 5.0 cm or less
in diameter is suitable for SNs study in gastric cancer.
Table 4 The correlation between clinicopathological factors and transversal and 2 stations lymph node metastasis
transversal metastasis 2 station positive nodes
factors - (%) + (%) x
2 P value - (%) + (%) x
2 P value
sex male 88 (58.3) 63 (41.7) 1.878 0.171 182 (81.3) 42 (18.7) 0.003 0.958
female 20 (46.5) 23 (53.5) 53 (81.5) 12 (18.5)
age (year) mean ± sd 58.4 ± 9.8 58.3 ± 11.5 0.005 0.942* 58.6 ± 10.2 59.5 ± 11.2 0.204 0.652*
tumor size(cm) mean ± sd 3.6 ± 1.1 3.5 ± 1.3 0.195 0.659* 3.9 ± 1.2 4.0 ± 1.0 0.581 0.446*
lymphadenec-tomy D2 81 (54.4) 68 (45.6) 0.445 0.505 168 (79.2) 44 (20.8) 2.243 0.134
more than D2 27 (60.0) 18 (40.0) 67 (87.0) 10 (13.0)
L 75 (52.4) 68 (47.6) 173 (83.6) 34 (16.4)
tumor site M 12 (75.0) 4 (25.0) 3.29 0.193 21 (75.0) 7 (25.0) 2.463 0.292
U 21 (60.0) 14 (40.0) 41 (75.9) 13 (24.1)
depth of tumor invasion T1 14 (58.3) 10 (41.7) 26 (92.9) 2 (7.1)
T2a 31 (49.2) 32 (50.8) 1.582 0.453 76 (82.6) 16 (17.4) 3.318 0.19
T2b 63 (58.9) 44 (41.1) 133 (78.7) 36 (21.3)
differentiation well/moderately 47 (54.0) 40 (46.0) 0.173 0.677 102 (79.1) 27 (20.9) 0.773 0.379
poorly 61 (57.0) 46 (43.0) 133 (83.1) 27 (16.9)
macroscopic type Borr. 1/2 22 (64.7) 12 (35.3) 1.523 0.217 47 (87.0) 7 (13.0) 2.068 0.15
Borr. 3/4 72 (52.9) 64 (47.1) 162 (78.3) 45 (21.7)
lauren type intestenal 41 (55.4) 33 (44.6) 85 (76.6) 26 (23.4)
diffused 64 (56.1) 50 (43.9) 0.09 0.956 142 (83.5) 28 (16.5) 4.027 0.134
mixed 3 (50.0) 3 (50.0) 8 (100.0) 0 (0.0)
lymphatic/venous invasion - 89 (55.3) 72 (44.7) 0.059 0.809 196 (80.7) 47 (19.3) 0.433 0.511
+ 19 (57.6) 14 (42.4) 39 (84.8) 7 (15.2)
note: * the difference was tested by unpaired t test.
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and who were all clinically staged as cT1/2cN0,a st h e s e
patients usually considered eligible for sentinel node
trial. It was reported that the sensitivity decreased and
false-negative rate increased with an increase of T stage
in SNB [10,17]. Only pT1-2 stage inclusion avoided the
bias due to the lymphatic obstruction in advanced gas-
tric carcinoma in SNB study. Third, patients with 1-3
positive nodes only restricted in the same compartment
based on JCGC classification were chosen. Isozaki H et
al. reported that two patients with sentinel nodes in no.
4d also had another lymph node metastasis at the lesser
curvature [17]. This phenomenon was also discovered
by Osaka H et al. from micrometastasis level [23]. In
their study, four patients with 2-5 blue-dyed nodes had
micrometastasis in 2-3 nodes. Considering the number
of SN per patient is 1-12 with an average of 3 and those
mentioned above, it is more reasonable that 1-3 positive
nodes in the same compartment are considered as the
initial lymphatic drainage sites (SNs).
In this study, we valuated the 1-3 positive nodes dis-
tribution and compared those with SLM. Most positive
nodes occurred in N1 compartment, with frequency
from 79.6% to 85.7% based on different tumor site. The
other 14.3% to 20.4% patients metastasized in N2 com-
partment directly without N1 involved. The no. 7, 8a, 9
and 11p stations were the most common sites. Our
results were consistent with other reports, in which
lymph node metastasis was distributed beyond the peri-
gastric area in 12.6% to 29.0% of gastric cancer patients
[15,16,21,24-26]. When compared with SLM, indeed
some differences existed in node distribution between
them. In patients located in the lower third of stomach
with 1-3 positive nodes, the frequency of no. 5 and no.
6 infiltrated was higher than that in SLM, and no. 6 was
the most common metastatic site, no. 3 was the second,
the order was reversed for SLM. Among the cancers of
other site, the location and distribution of positive
nodes in N1 and N2 (skip metastasis) was similar. This
is a novel insight about SNs distribution in gastric can-
cer that never reported before.
To know the distribution of the SNs contributes to
choose more suitable lymphadenectomy. In the present
study, transverse metastasis was quite common,
amounted to 41.2% and 50.8% in the lesser and greater
curvature, respectively. Ther a t ei sal i t t l eh i g h e rt h a n
previous reports [21,24]. The patients with more than
one positive node included in this study maybe the
main reason. It was also frequent that two stations were
involved simultaneously, most of which occurred in the
neighboring or opposite stations in the same compart-
ment. Furthermore, with increasing the depth of tumor
invasion, a progressively augmented nodal involvement
was showed, including the number of stations involved
a n dt h ef r e q u e n c yo fs o m es t a t i o n se s p e c i a l l yi nN 2
compartment. 4 patients in the upper third of stomach
with two stations involved in N2 compartment were all
proved as ss (pT2b) pathologically. All of above indicate
that single lymph node dissection is not recommended,
and the en-bloc dissection of lymphatic basins from the
cancer should be performed to avoid the occurrence of
false negative SLN, in the context of SLN biopsy, as the
existence of high frequency of transversal and 2 stations
lymph node metastasis.
Achieving an R0 resection is a critical step in obtain-
ing local-regional control, but limitting the extent of
lymphadenectomy is apt to expose some patients to the
possibility of incomplete dissection. Skip metastasis was
found in 14.3%-20.4% patients with 1-3 metastatic
lymph nodes. When the influenced factors on skip
metastasis were analyzed, none was found to be asso-
ciated with it. This was also confirmed by Li C and Park
SS [14,27]. Of note, the prognosis of patients with skip
metastasis was as similar as that without skip metastasis
after D2 or D3 lymphadenectomy. This means that in
cases where metastasis first occurs in N2, the function
of N2 in this situation is considered to be the same as
N1. It suggests that we would achieve good surgical out-
come if skip metastasis is found and dissected thor-
oughly. In order to obtain regional control, D2
lymphadenectomy is essential in patients with pT2
stage, as the higher occurrence of skip metastasis and
higher frequency of some stations involved in N2 com-
partment in these patients.
Conclusions
In a word, although the results from this study don’t
present the distribution of SN in gastric carcinoma
directly, they could provide some valuable information
Figure 1 Survival curves of patients with and without skip
metastasis. No significant difference was detected among patients
with and without skip metastasis (x
2 = 0.168, p = 0.1951).
Huang et al. BMC Cancer 2011, 11:18
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conclude that 1-3 positive nodes in the same compart-
ment should be possible SNs, and most of which are
restricted in N1 in pT1-2 gastric cancer. Transversal
and 2 stations lymph node metastasis are common.
List of Abbreviations
SN: refers to sentinel node; SLM: refers to solitary lymph node metastasis;
SNB: refers to sentinel node biopsy; sm: refers to submucosa based on
depth of tumor invasion; mp: refers to muscularis propria based on depth of
tumor invasion; ss: refers to subserosa based on depth of tumor invasion.
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